Epoch 30 - No More Small Molecule Medicines from Biotech?

A Poorly Crafted Drug Pricing Reform Bill Promises to Crush Innovation

Hello Avatar! Welcome back for another week of biotech analysis.  This week we reluctantly dive into the topic of public health policy.  We say reluctantly because for the most part we prefer to stick to the topic of innovation.  However, the recent Prescription Drug Pricing Reform Bill will significantly impact innovation in such a negative way we had …